Enzyme-Empowered "Two Birds with One Stone" Strategy for Amplifying Tumor Apoptosis and Metabolic Clearance
Hanyue Li1, Yihui Li2, Lina Su3
1State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300192, P. R. China.
Abstract:
Nanomedicine has reshaped the landscape of cancer treatment. However, its efficacy is still hampered by innate tumor defense systems that rely on adenosine triphosphate (ATP) for fuel, including damage repair, apoptosis resistance, and immune evasion. Inspired by the naturally enzymatic reaction of glucose oxidase (GOx) with glucose, here a novel "two birds with one stone" technique for amplifying enzyme-mediated tumor apoptosis and enzyme-promoted metabolic clearance is proposed and achieved using GOx-functionalized rhenium nanoclusters-doped polypyrrole (Re@ReP-G). Re@ReP-G reduces ATP production while increasing H2O2 concentrations in the tumor microenvironment through GOx-induced enzymatic oxidation, which in turn results in the downregulation of defense (HSP70 and HSP90) and anti-apoptotic Bcl-2 proteins, the upregulation of pro-apoptotic Bax, and the release of cytochrome c. These processes are further facilitated by laser-induced hyperthermia effect, ultimately leading to severe tumor apoptosis. As an enzymatic byproduct, H2O2 catalyzes the conversion of rhenium nanoclusters in Re@ReP-G nanostructures into rhenate from the outside in, which accelerates their metabolic clearance in vivo. This Re@ReP-G-based "two birds with one stone" therapeutic strategy provides an effective tool for amplifying tumor apoptosis and safe metabolic mechanisms.
Insights
This study introduces Re@ReP-G, a nanomedicine that enhances cancer apoptosis by depleting tumor energy (ATP) and increasing hydrogen peroxide. This dual action also promotes safe metabolic clearance of the nanomedicine.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Nanomedicine faces challenges in cancer treatment due to tumor defense mechanisms fueled by adenosine triphosphate (ATP).
- Tumor defenses include DNA repair, resistance to programmed cell death (apoptosis), and immune evasion, all relying on ATP.
- Overcoming these ATP-dependent defenses is crucial for improving nanomedicine efficacy.
Purpose of the Study:
- To develop a novel nanomedicine strategy to amplify enzyme-mediated tumor apoptosis and promote metabolic clearance.
- To create a dual-action approach targeting both tumor energy supply and nanomedicine clearance.
- To utilize glucose oxidase (GOx) and functionalized rhenium nanoclusters for enhanced cancer therapy.
Main Methods:
- A novel nanomedicine, GOx-functionalized rhenium nanoclusters-doped polypyrrole (Re@ReP-G), was synthesized.
- Re@ReP-G was designed to reduce ATP production and increase hydrogen peroxide (H2O2) via GOx enzymatic activity.
- Laser-induced hyperthermia was employed to further enhance tumor apoptosis.
Main Results:
- Re@ReP-G effectively reduced ATP production and increased H2O2 in the tumor microenvironment.
- This led to downregulation of protective proteins (HSP70, HSP90, Bcl-2) and upregulation of pro-apoptotic protein Bax.
- Cytochrome c release and severe tumor apoptosis were observed, alongside accelerated in vivo metabolic clearance of the nanomedicine.
Conclusions:
- The Re@ReP-G nanomedicine offers a "two birds with one stone" strategy for cancer therapy.
- It amplifies tumor apoptosis by disrupting energy metabolism and inducing cell death pathways.
- The strategy also ensures safe and efficient metabolic clearance of the nanomedicine in vivo.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Treatment Resistant Cancers


